PARSIPPANY, N.J.--(BUSINESS WIRE)--Nov. 1, 2013--
Pacira
Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that
Dave Stack, president, chief executive officer and chairman of Pacira
Pharmaceuticals, is scheduled to present an overview of the company at
investor conferences during November.
-
Mr. Stack will present at the Goldman Sachs US Emerging / SMID Cap
Growth Conference on Thursday, November 14, 2013, at 2:40 p.m. ET in
New York.
-
Mr. Stack will present at the Jefferies 2013 Global Healthcare
Conference on Thursday, November 21, 2013, at 9:20 a.m. BST (4:20 a.m.
ET) in London, UK.
A live audio webcast of these Pacira presentations can be accessed by
visiting the “Investors & Media” section of the company’s website at investor.pacira.com.
Replays of the webcasts will be archived on the Pacira website for two
weeks following the presentation dates.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) is an emerging specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s current emphasis is the
development of non-opioid products for postsurgical pain control, and
its lead product, EXPAREL® (bupivacaine liposome injectable
suspension), was commercially launched in the United States in April
2012. EXPAREL and two other products have utilized the Pacira
proprietary product delivery technology DepoFoam®, a unique
platform that encapsulates drugs without altering their molecular
structure and then releases them over a desired period of time.
Additional information about Pacira is available at www.pacira.com.
Source: Pacira Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc.
Jessica Cho, 973-254-3574
Investor
Relations Associate
Jessica.Cho@pacira.com
